Tower Research Capital (TRC)’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Tower Research Capital (TRC)’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-47	Closed	-$110	–	6183
2024 Q3	$110	Sell	47 -153	-77%	-$309	﹤0.01%	5506
2024 Q2	$176	Sell	200 -16,310	-99%	-$33.6K	﹤0.01%	5421
2024 Q1	$67.5K	Buy	16,510 +8,448	+105%	+$37.8K	﹤0.01%	2081
2023 Q4	$47.2K	Sell	8,062 -28,766	-78%	-$151K	﹤0.01%	3167
2023 Q3	$190K	Buy	+36,828	New	+$173K	0.01%	1463
2023 Q2	–	Sell	-105	Closed	–	–	6439
2023 Q1	$0	Sell	105 -2,745	-96%	-$4.48K	﹤0.01%	6433
2022 Q4	$4K	Sell	2,850 -3,608	-56%	-$4.6K	﹤0.01%	5100
2022 Q3	$9K	Sell	6,458 -980	-13%	-$1.68K	﹤0.01%	4717
2022 Q2	$13K	Buy	7,438 +6,775	+1,022%	+$15.7K	﹤0.01%	4238
2022 Q1	$2K	Sell	663 -377	-36%	-$1.02K	﹤0.01%	5630
2021 Q4	$3K	Buy	+1,040	New	+$3.77K	﹤0.01%	5521

Tower Research Capital (TRC)'s AUGX Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 47 shares — an estimated $110 sold.

Tower Research Capital (TRC) first reported a position in AUGX in Q4 2021 and held it in 11 quarters. The position peaked at $190K in Q3 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Tower Research Capital (TRC) reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 47 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $110.
Tower Research Capital (TRC) first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Tower Research Capital (TRC)'s Augmedix, Inc. Common Stock position peaked at $190K in Q3 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.